US Generics Market Heading for Stupendous Growth

With key blockbuster drugs going off-patent in coming years, generics will account for around 80% of the total number of prescriptions dispensed in the US, says RNCOS in its latest report.

NOIDA, India (prHWY.com) September 16, 2011 - According to our recent research report, "Booming US Generic Drug Market", the growth of generics industry in the US continued despite recessionary pressures and after-impact of slow down. The number of generic products launched in the market has increased considerably over the past few years, depicting a picture of significant profits and effective private sector participation. The generic drugs industry in the US was valued at US$ 81.5 Billion in 2010 and with key drugs going off-patent in days to come; the market is likely to cross the mark of US$ 100 Billion by 2013.

Our researchers have prudently analyzed that generics may account for around 80% of the total number of prescriptions dispensed in the US by 2013 in volume terms. However, in value terms, the share of generic drugs in the total US pharmaceutical market is expected to be around 28% during the same period. This exhibits that the availability of generic drugs is at low cost in the country. In such a case, the quality is considered to be a major concern for patients despite FDA intervention.

The report, "Booming US Generic Drug Market", effectively depicts the performance of the US generic drugs market by prudently evaluating all the collected information and presenting it in a chronological order. The report investigates all the key market trends and analyzes their impact on the market development. Moreover, the report also provides segment-wise analysis of the industry along with regulatory initiatives that may shape up the future state of generics in the US.

The report is an outcome of an extensive research and in-depth analysis of the US generic drugs market. It effectively identifies possible areas of growth in terms of technological developments, payment patterns, and the country's regulatory environment. Based on these trends and factors, the report presents a rational analysis of the performance of the US generics industry. Overall, the report is meant to provide potential clients with an optimum source of knowledge and market statistics with respect to the US generics industry.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM589.htm

Check DISCOUNTED REPORTS on: http://www.rncos.com/promotion.htm

About RNCOS:

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.

###

Tag Words: generics market us

Categories: Health

Press Release Contact
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707

Link To This Press Release:

URL HTML Code